A novel variant in CYFIP2 in a girl with severe disabilities and bilateral perisylvian polymicrogyria




Salokivi, Tommi; Parkkola, Riitta; Rajendran, Yasmin; Bharadwaj, Thashi; Acharya, Anushree; Leal, Suzanne M., Järvelä, Irma; Arvio, Maria; Schrauwen, Isabelle

PublisherWiley

2024

 American Journal of Medical Genetics Part A

AMERICAN JOURNAL OF MEDICAL GENETICS PART A

e63478

194

4

1552-4825

1552-4833

DOIhttps://doi.org/10.1002/ajmg.a.63478

http://dx.doi.org/10.1002%2Fajmg.a.63478

https://research.utu.fi/converis/portal/detail/Publication/182384787



Bilateral perisylvian polymicrogyria (BPP) is a structural malformation of the cerebral cortex that can be caused by several genetic abnormalities. The most common clinical manifestations of BPP include intellectual disability and epilepsy. Cytoplasmic FMRP-interacting protein 2 (CYFIP2) is a protein that interacts with the fragile X mental retardation protein (FMRP). CYFIP2 variants can cause various brain structural abnormalities with the most common clinical manifestations of intellectual disability, epileptic encephalopathy and dysmorphic features. We present a girl with multiple disabilities and BPP caused by a heterozygous, novel, likely pathogenic variant (c.1651G>C: p.(Val551Leu) in the CYFIP2 gene. Our case report broadens the spectrum of genetic diversity associated with BPP by incorporating CYFIP2.


Last updated on 17/03/2026 07:03:37 AM